ACHILLES THERAPEUTICS PL-ADR (ACHL)
US00449L1026 - ADR
ChartMill assigns a Buy % Consensus number of 78% to ACHL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.89. This target is 204.91% above the current price.
ACHL was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ACHL.
In the previous month the buy percentage consensus was at a similar level.
ACHL was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-04-05 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-12-14 | B of A Securities | Downgrade | Buy -> Underperform |
| 2023-08-07 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-05-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2022-12-07 | Chardan Capital | Maintains | Buy |
| 2022-12-07 | Piper Sandler | Maintains | Overweight |
| 2021-04-26 | Chardan Capital | Initiate | Buy |
| 2021-04-26 | Oppenheimer | Initiate | Outperform |
| 2021-04-26 | JP Morgan | Initiate | Underweight |
| 2021-04-26 | B of A Securities | Initiate | Buy |
| 2021-04-26 | Piper Sandler | Initiate | Overweight |